Latest News about BLU
Recent news which mentions BLU
   From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
   
  
  
  July 07, 2023
  From Benzinga
 
   GSK Stock: A Value Trap or a Hidden Gem?
   
  
  
  April 27, 2023
  From InvestorPlace
 
   3 Biotechs That Might Get Bought Out in 2023
   
  
  
  April 26, 2023
  From Motley Fool
 
   Was This Acquisition a Savvy Play by This Big Pharma Stock?
   
  
  
  April 26, 2023
  From Motley Fool
 
   Why This Nasdaq Stock Caught Fire This Week
   
  
  
  April 20, 2023
  From Motley Fool
 
   Why Shares of Bellus Health Skyrocketed This Week
   
  
  
  April 20, 2023
  From Motley Fool
 From Benzinga
 
   Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings
   
  
  
  April 18, 2023
  From Benzinga
 
   Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  April 18, 2023
  From Benzinga
 From Benzinga
 
   Why BELLUS Health Stock Is Rocketing Higher Today
   
  
  
  April 18, 2023
  From Motley Fool
 From Benzinga
 
   US Stocks Mixed; Housing Starts Edge Lower In March
   
  
  
  April 18, 2023
  From Benzinga
 From Benzinga
 
   Why Is Gamida Cell (GMDA) Stock Up 48% Today?
   
  
  
  April 18, 2023
  From InvestorPlace
 
   Why Is ContraFect (CFRX) Stock Down 14% Today?
   
  
  
  April 18, 2023
  From InvestorPlace
 
   Why Is VirnetX (VHC) Stock Down 63% Today?
   
  
  
  April 18, 2023
  From InvestorPlace
 
   Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
   
  
  
  April 18, 2023
  From MarketWatch
 
   Why Is Bellus Health (BLU) Stock Up 98% Today?
   
  
  
  April 18, 2023
  From InvestorPlace
 
   Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
   
  
  
  April 18, 2023
  From Benzinga
 From InvestorPlace
 From MarketWatch
 
   BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
   
  
  
  April 18, 2023
  From Benzinga
 
   GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
   
  
  
  April 18, 2023
  From Benzinga
 
   GSK to acquire U.S.-based BELLUS Health for $14.75 per share
   
  
  
  April 18, 2023
  From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
